Dr. Thomas A. Mcfarland

Jacqueline Mullvain is a Hematologist and an Oncologist practicing medicine in Madison, Wisconsin. Dr. Mullvain is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. Dr. Mullvain is board certified in American Board Of IM/Hematology , Wisconsin Medical Examining Board, American Board Of Internal Medicine , Drug Enforcement Administration , and American Board Of IM/Medical Oncology .

Julie Chang is a Hematologist and an Oncologist practicing medicine in Madison, Wisconsin. Dr. Chang is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Bone Marrow Aspiration. Dr. Chang is board certified in American Board Of IM/Hematology , Wisconsin Medical Examining Board, and Drug Enforcement Administration . Dr. Chang is currently accepting new patients.

Dr. O'Mahar is a board certified oncologist. She obtained her undergraduate degree from Stanford University and earned her medical degree from the Washington University School of Medicine in St. Louis. She completed her internship at Barnes-Jewish Hospital in St. Louis and her fellowship at the University of Wisconsin - Madison. Her area of expertise is the treatment of multiple myeloma, myelodysplastic syndromes, monoclonal gammopathy, melanoma and acute and chronic leukemia. In her free time, Dr. O'Mahar enjoys baking and writing sort stories and poetry. Dr. O'mahar is highly rated in 45 conditions, according to our data. Her clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Myelodysplastic Syndrome (MDS), and Waldenstrom Macroglobulinemia. Dr. O'mahar is board certified in American Board Of IM/Hematology , Wisconsin Medical Examining Board, American Board Of Internal Medicine , Drug Enforcement Administration , and American Board Of IM/Medical Oncology .